nodes	percent_of_prediction	percent_of_DWPC	metapath
Milrinone—PDE3A—Anagrelide—hematologic cancer	0.816	1	CbGbCtD
Milrinone—Amrinone—PDE4B—hematologic cancer	0.00418	0.639	CrCbGaD
Milrinone—Amrinone—TNF—hematologic cancer	0.00237	0.361	CrCbGaD
Milrinone—Chest pain—Nilotinib—hematologic cancer	0.000398	0.00238	CcSEcCtD
Milrinone—Chest pain—Imatinib—hematologic cancer	0.000396	0.00237	CcSEcCtD
Milrinone—Hypotension—Procarbazine—hematologic cancer	0.000394	0.00235	CcSEcCtD
Milrinone—Chest pain—Cladribine—hematologic cancer	0.000389	0.00233	CcSEcCtD
Milrinone—Hypotension—Dasatinib—hematologic cancer	0.000386	0.00231	CcSEcCtD
Milrinone—Arrhythmia—Bortezomib—hematologic cancer	0.000383	0.00229	CcSEcCtD
Milrinone—Thrombocytopenia—Chlorambucil—hematologic cancer	0.000382	0.00228	CcSEcCtD
Milrinone—Tremor—Lenalidomide—hematologic cancer	0.00038	0.00227	CcSEcCtD
Milrinone—Anaphylactic shock—Imatinib—hematologic cancer	0.00038	0.00227	CcSEcCtD
Milrinone—PDE3A—hematopoietic system—hematologic cancer	0.000378	0.314	CbGeAlD
Milrinone—Arrhythmia—Vinorelbine—hematologic cancer	0.000374	0.00223	CcSEcCtD
Milrinone—Thrombocytopenia—Nilotinib—hematologic cancer	0.000374	0.00223	CcSEcCtD
Milrinone—Thrombocytopenia—Imatinib—hematologic cancer	0.000372	0.00222	CcSEcCtD
Milrinone—Thrombocytopenia—Cladribine—hematologic cancer	0.000365	0.00218	CcSEcCtD
Milrinone—Arrhythmia—Thiotepa—hematologic cancer	0.000357	0.00213	CcSEcCtD
Milrinone—Hypotension—Nilotinib—hematologic cancer	0.000357	0.00213	CcSEcCtD
Milrinone—Chest pain—Melphalan—hematologic cancer	0.000355	0.00212	CcSEcCtD
Milrinone—Ventricular extrasystoles—Epirubicin—hematologic cancer	0.000355	0.00212	CcSEcCtD
Milrinone—Hypotension—Imatinib—hematologic cancer	0.000355	0.00212	CcSEcCtD
Milrinone—Bronchospasm—Etoposide—hematologic cancer	0.000353	0.00211	CcSEcCtD
Milrinone—Thrombocytopenia—Vinblastine—hematologic cancer	0.00035	0.00209	CcSEcCtD
Milrinone—Tremor—Bortezomib—hematologic cancer	0.000349	0.00209	CcSEcCtD
Milrinone—Hypotension—Cladribine—hematologic cancer	0.000349	0.00208	CcSEcCtD
Milrinone—Arrhythmia—Thalidomide—hematologic cancer	0.000345	0.00206	CcSEcCtD
Milrinone—Chest pain—Lenalidomide—hematologic cancer	0.000345	0.00206	CcSEcCtD
Milrinone—Anaphylactic shock—Melphalan—hematologic cancer	0.00034	0.00203	CcSEcCtD
Milrinone—Headache—Nelarabine—hematologic cancer	0.000336	0.00201	CcSEcCtD
Milrinone—Thrombocytopenia—Melphalan—hematologic cancer	0.000333	0.00199	CcSEcCtD
Milrinone—Arrhythmia—Carmustine—hematologic cancer	0.000332	0.00198	CcSEcCtD
Milrinone—Rash—Methoxsalen—hematologic cancer	0.00033	0.00198	CcSEcCtD
Milrinone—Dermatitis—Methoxsalen—hematologic cancer	0.00033	0.00197	CcSEcCtD
Milrinone—Arrhythmia—Alitretinoin—hematologic cancer	0.000328	0.00196	CcSEcCtD
Milrinone—Headache—Methoxsalen—hematologic cancer	0.000328	0.00196	CcSEcCtD
Milrinone—Ventricular extrasystoles—Doxorubicin—hematologic cancer	0.000328	0.00196	CcSEcCtD
Milrinone—Arrhythmia—Ifosfamide—hematologic cancer	0.000325	0.00194	CcSEcCtD
Milrinone—Thrombocytopenia—Lenalidomide—hematologic cancer	0.000324	0.00194	CcSEcCtD
Milrinone—Rash—Mercaptopurine—hematologic cancer	0.000321	0.00192	CcSEcCtD
Milrinone—Dermatitis—Mercaptopurine—hematologic cancer	0.000321	0.00192	CcSEcCtD
Milrinone—Ventricular tachycardia—Epirubicin—hematologic cancer	0.00032	0.00192	CcSEcCtD
Milrinone—Thrombocytopenia—Hydroxyurea—hematologic cancer	0.000319	0.00191	CcSEcCtD
Milrinone—Hypotension—Melphalan—hematologic cancer	0.000318	0.0019	CcSEcCtD
Milrinone—Chest pain—Bortezomib—hematologic cancer	0.000318	0.0019	CcSEcCtD
Milrinone—Rash—Daunorubicin—hematologic cancer	0.000317	0.00189	CcSEcCtD
Milrinone—Rash—Clofarabine—hematologic cancer	0.000317	0.00189	CcSEcCtD
Milrinone—Dermatitis—Clofarabine—hematologic cancer	0.000316	0.00189	CcSEcCtD
Milrinone—Dermatitis—Daunorubicin—hematologic cancer	0.000316	0.00189	CcSEcCtD
Milrinone—Tremor—Thalidomide—hematologic cancer	0.000315	0.00188	CcSEcCtD
Milrinone—Chest pain—Bleomycin—hematologic cancer	0.000315	0.00188	CcSEcCtD
Milrinone—Rash—Pentostatin—hematologic cancer	0.000315	0.00188	CcSEcCtD
Milrinone—Rash—Anagrelide—hematologic cancer	0.000315	0.00188	CcSEcCtD
Milrinone—Dermatitis—Pentostatin—hematologic cancer	0.000315	0.00188	CcSEcCtD
Milrinone—Dermatitis—Anagrelide—hematologic cancer	0.000315	0.00188	CcSEcCtD
Milrinone—Headache—Clofarabine—hematologic cancer	0.000314	0.00188	CcSEcCtD
Milrinone—Headache—Daunorubicin—hematologic cancer	0.000314	0.00188	CcSEcCtD
Milrinone—Headache—Anagrelide—hematologic cancer	0.000313	0.00187	CcSEcCtD
Milrinone—Headache—Pentostatin—hematologic cancer	0.000313	0.00187	CcSEcCtD
Milrinone—Hypokalaemia—Dexamethasone—hematologic cancer	0.000311	0.00186	CcSEcCtD
Milrinone—Hypokalaemia—Betamethasone—hematologic cancer	0.000311	0.00186	CcSEcCtD
Milrinone—Chest pain—Vinorelbine—hematologic cancer	0.00031	0.00185	CcSEcCtD
Milrinone—Hypotension—Lenalidomide—hematologic cancer	0.000309	0.00185	CcSEcCtD
Milrinone—Arrhythmia—Irinotecan—hematologic cancer	0.000308	0.00184	CcSEcCtD
Milrinone—Arrhythmia—Mitoxantrone—hematologic cancer	0.000308	0.00184	CcSEcCtD
Milrinone—Anaphylactic shock—Bortezomib—hematologic cancer	0.000304	0.00182	CcSEcCtD
Milrinone—Rash—Idarubicin—hematologic cancer	0.000304	0.00182	CcSEcCtD
Milrinone—Dermatitis—Idarubicin—hematologic cancer	0.000304	0.00181	CcSEcCtD
Milrinone—Tremor—Carmustine—hematologic cancer	0.000303	0.00181	CcSEcCtD
Milrinone—Anaphylactic shock—Bleomycin—hematologic cancer	0.000302	0.00181	CcSEcCtD
Milrinone—Headache—Idarubicin—hematologic cancer	0.000302	0.0018	CcSEcCtD
Milrinone—Arrhythmia—Gemcitabine—hematologic cancer	0.0003	0.0018	CcSEcCtD
Milrinone—Tremor—Alitretinoin—hematologic cancer	0.0003	0.00179	CcSEcCtD
Milrinone—Thrombocytopenia—Bortezomib—hematologic cancer	0.000298	0.00178	CcSEcCtD
Milrinone—Anaphylactic shock—Vinorelbine—hematologic cancer	0.000297	0.00178	CcSEcCtD
Milrinone—Ventricular tachycardia—Doxorubicin—hematologic cancer	0.000296	0.00177	CcSEcCtD
Milrinone—Thrombocytopenia—Bleomycin—hematologic cancer	0.000296	0.00177	CcSEcCtD
Milrinone—Rash—Teniposide—hematologic cancer	0.000296	0.00177	CcSEcCtD
Milrinone—Dermatitis—Teniposide—hematologic cancer	0.000295	0.00177	CcSEcCtD
Milrinone—Headache—Teniposide—hematologic cancer	0.000294	0.00176	CcSEcCtD
Milrinone—Thrombocytopenia—Vinorelbine—hematologic cancer	0.000291	0.00174	CcSEcCtD
Milrinone—Chest pain—Thalidomide—hematologic cancer	0.000286	0.00171	CcSEcCtD
Milrinone—Hypotension—Bortezomib—hematologic cancer	0.000284	0.0017	CcSEcCtD
Milrinone—Hypotension—Bleomycin—hematologic cancer	0.000282	0.00169	CcSEcCtD
Milrinone—Arrhythmia—Cisplatin—hematologic cancer	0.00028	0.00167	CcSEcCtD
Milrinone—Thrombocytopenia—Thiotepa—hematologic cancer	0.000278	0.00166	CcSEcCtD
Milrinone—Hypotension—Vinorelbine—hematologic cancer	0.000278	0.00166	CcSEcCtD
Milrinone—Chest pain—Carmustine—hematologic cancer	0.000275	0.00164	CcSEcCtD
Milrinone—Rash—Busulfan—hematologic cancer	0.000274	0.00164	CcSEcCtD
Milrinone—Dermatitis—Busulfan—hematologic cancer	0.000274	0.00164	CcSEcCtD
Milrinone—Chest pain—Alitretinoin—hematologic cancer	0.000273	0.00163	CcSEcCtD
Milrinone—Headache—Busulfan—hematologic cancer	0.000272	0.00163	CcSEcCtD
Milrinone—Hypokalaemia—Prednisone—hematologic cancer	0.000271	0.00162	CcSEcCtD
Milrinone—Chest pain—Ifosfamide—hematologic cancer	0.000269	0.00161	CcSEcCtD
Milrinone—Thrombocytopenia—Thalidomide—hematologic cancer	0.000269	0.00161	CcSEcCtD
Milrinone—Rash—Procarbazine—hematologic cancer	0.000266	0.00159	CcSEcCtD
Milrinone—Dermatitis—Procarbazine—hematologic cancer	0.000266	0.00159	CcSEcCtD
Milrinone—Headache—Procarbazine—hematologic cancer	0.000264	0.00158	CcSEcCtD
Milrinone—Anaphylactic shock—Alitretinoin—hematologic cancer	0.000261	0.00156	CcSEcCtD
Milrinone—Rash—Bexarotene—hematologic cancer	0.000261	0.00156	CcSEcCtD
Milrinone—Rash—Dasatinib—hematologic cancer	0.000261	0.00156	CcSEcCtD
Milrinone—Dermatitis—Dasatinib—hematologic cancer	0.00026	0.00156	CcSEcCtD
Milrinone—Dermatitis—Bexarotene—hematologic cancer	0.00026	0.00156	CcSEcCtD
Milrinone—Rash—Fludarabine—hematologic cancer	0.00026	0.00155	CcSEcCtD
Milrinone—Dermatitis—Fludarabine—hematologic cancer	0.00026	0.00155	CcSEcCtD
Milrinone—Headache—Dasatinib—hematologic cancer	0.000259	0.00155	CcSEcCtD
Milrinone—Headache—Bexarotene—hematologic cancer	0.000259	0.00155	CcSEcCtD
Milrinone—Thrombocytopenia—Carmustine—hematologic cancer	0.000258	0.00154	CcSEcCtD
Milrinone—Anaphylactic shock—Ifosfamide—hematologic cancer	0.000258	0.00154	CcSEcCtD
Milrinone—Headache—Fludarabine—hematologic cancer	0.000258	0.00154	CcSEcCtD
Milrinone—Hypotension—Thalidomide—hematologic cancer	0.000257	0.00153	CcSEcCtD
Milrinone—Thrombocytopenia—Alitretinoin—hematologic cancer	0.000256	0.00153	CcSEcCtD
Milrinone—Chest pain—Mitoxantrone—hematologic cancer	0.000256	0.00153	CcSEcCtD
Milrinone—Tremor—Cisplatin—hematologic cancer	0.000256	0.00153	CcSEcCtD
Milrinone—Arrhythmia—Prednisolone—hematologic cancer	0.000253	0.00151	CcSEcCtD
Milrinone—Thrombocytopenia—Ifosfamide—hematologic cancer	0.000253	0.00151	CcSEcCtD
Milrinone—Anaphylactic shock—Vincristine—hematologic cancer	0.000252	0.0015	CcSEcCtD
Milrinone—PDE3A—blood—hematologic cancer	0.000251	0.208	CbGeAlD
Milrinone—Chest pain—Gemcitabine—hematologic cancer	0.000249	0.00149	CcSEcCtD
Milrinone—Thrombocytopenia—Vincristine—hematologic cancer	0.000246	0.00147	CcSEcCtD
Milrinone—Hypotension—Carmustine—hematologic cancer	0.000246	0.00147	CcSEcCtD
Milrinone—Anaphylactic shock—Irinotecan—hematologic cancer	0.000245	0.00147	CcSEcCtD
Milrinone—Anaphylactic shock—Mitoxantrone—hematologic cancer	0.000245	0.00147	CcSEcCtD
Milrinone—Hypotension—Alitretinoin—hematologic cancer	0.000244	0.00146	CcSEcCtD
Milrinone—Hypotension—Ifosfamide—hematologic cancer	0.000241	0.00144	CcSEcCtD
Milrinone—Rash—Nilotinib—hematologic cancer	0.000241	0.00144	CcSEcCtD
Milrinone—Dermatitis—Nilotinib—hematologic cancer	0.00024	0.00144	CcSEcCtD
Milrinone—Thrombocytopenia—Mitoxantrone—hematologic cancer	0.00024	0.00144	CcSEcCtD
Milrinone—Thrombocytopenia—Irinotecan—hematologic cancer	0.00024	0.00144	CcSEcCtD
Milrinone—Rash—Imatinib—hematologic cancer	0.000239	0.00143	CcSEcCtD
Milrinone—Headache—Nilotinib—hematologic cancer	0.000239	0.00143	CcSEcCtD
Milrinone—Dermatitis—Imatinib—hematologic cancer	0.000239	0.00143	CcSEcCtD
Milrinone—Anaphylactic shock—Gemcitabine—hematologic cancer	0.000239	0.00143	CcSEcCtD
Milrinone—Headache—Imatinib—hematologic cancer	0.000238	0.00142	CcSEcCtD
Milrinone—Hypotension—Vincristine—hematologic cancer	0.000235	0.00141	CcSEcCtD
Milrinone—Rash—Cladribine—hematologic cancer	0.000235	0.00141	CcSEcCtD
Milrinone—Dermatitis—Cladribine—hematologic cancer	0.000235	0.0014	CcSEcCtD
Milrinone—Thrombocytopenia—Gemcitabine—hematologic cancer	0.000234	0.0014	CcSEcCtD
Milrinone—Headache—Cladribine—hematologic cancer	0.000234	0.0014	CcSEcCtD
Milrinone—Arrhythmia—Triamcinolone—hematologic cancer	0.000233	0.00139	CcSEcCtD
Milrinone—Liver function test abnormal—Methotrexate—hematologic cancer	0.000229	0.00137	CcSEcCtD
Milrinone—Hypotension—Irinotecan—hematologic cancer	0.000229	0.00137	CcSEcCtD
Milrinone—Hypotension—Mitoxantrone—hematologic cancer	0.000229	0.00137	CcSEcCtD
Milrinone—Headache—Vinblastine—hematologic cancer	0.000224	0.00134	CcSEcCtD
Milrinone—Hypotension—Gemcitabine—hematologic cancer	0.000223	0.00133	CcSEcCtD
Milrinone—Anaphylactic shock—Cisplatin—hematologic cancer	0.000223	0.00133	CcSEcCtD
Milrinone—PDE3A—lung—hematologic cancer	0.00022	0.182	CbGeAlD
Milrinone—Thrombocytopenia—Cisplatin—hematologic cancer	0.000218	0.0013	CcSEcCtD
Milrinone—Liver function test abnormal—Epirubicin—hematologic cancer	0.000215	0.00128	CcSEcCtD
Milrinone—Rash—Melphalan—hematologic cancer	0.000215	0.00128	CcSEcCtD
Milrinone—Dermatitis—Melphalan—hematologic cancer	0.000214	0.00128	CcSEcCtD
Milrinone—Chest pain—Etoposide—hematologic cancer	0.000213	0.00127	CcSEcCtD
Milrinone—Hypokalaemia—Epirubicin—hematologic cancer	0.000212	0.00127	CcSEcCtD
Milrinone—Arrhythmia—Dexamethasone—hematologic cancer	0.000211	0.00126	CcSEcCtD
Milrinone—Arrhythmia—Betamethasone—hematologic cancer	0.000211	0.00126	CcSEcCtD
Milrinone—Rash—Lenalidomide—hematologic cancer	0.000209	0.00125	CcSEcCtD
Milrinone—Dermatitis—Lenalidomide—hematologic cancer	0.000208	0.00125	CcSEcCtD
Milrinone—Hypotension—Cisplatin—hematologic cancer	0.000208	0.00124	CcSEcCtD
Milrinone—PDE3A—testis—hematologic cancer	0.000207	0.172	CbGeAlD
Milrinone—Headache—Lenalidomide—hematologic cancer	0.000207	0.00124	CcSEcCtD
Milrinone—Rash—Hydroxyurea—hematologic cancer	0.000206	0.00123	CcSEcCtD
Milrinone—Dermatitis—Hydroxyurea—hematologic cancer	0.000205	0.00123	CcSEcCtD
Milrinone—Headache—Hydroxyurea—hematologic cancer	0.000204	0.00122	CcSEcCtD
Milrinone—Anaphylactic shock—Etoposide—hematologic cancer	0.000204	0.00122	CcSEcCtD
Milrinone—Anaphylactic shock—Prednisolone—hematologic cancer	0.000201	0.0012	CcSEcCtD
Milrinone—Thrombocytopenia—Etoposide—hematologic cancer	0.0002	0.00119	CcSEcCtD
Milrinone—Liver function test abnormal—Doxorubicin—hematologic cancer	0.000199	0.00119	CcSEcCtD
Milrinone—Hypokalaemia—Doxorubicin—hematologic cancer	0.000196	0.00117	CcSEcCtD
Milrinone—Angina pectoris—Epirubicin—hematologic cancer	0.000196	0.00117	CcSEcCtD
Milrinone—Rash—Bortezomib—hematologic cancer	0.000192	0.00115	CcSEcCtD
Milrinone—Dermatitis—Bortezomib—hematologic cancer	0.000192	0.00115	CcSEcCtD
Milrinone—Headache—Bortezomib—hematologic cancer	0.000191	0.00114	CcSEcCtD
Milrinone—Hypotension—Etoposide—hematologic cancer	0.000191	0.00114	CcSEcCtD
Milrinone—Rash—Bleomycin—hematologic cancer	0.00019	0.00114	CcSEcCtD
Milrinone—Dermatitis—Bleomycin—hematologic cancer	0.00019	0.00114	CcSEcCtD
Milrinone—Rash—Vinorelbine—hematologic cancer	0.000187	0.00112	CcSEcCtD
Milrinone—Dermatitis—Vinorelbine—hematologic cancer	0.000187	0.00112	CcSEcCtD
Milrinone—Headache—Vinorelbine—hematologic cancer	0.000186	0.00111	CcSEcCtD
Milrinone—Anaphylactic shock—Triamcinolone—hematologic cancer	0.000185	0.00111	CcSEcCtD
Milrinone—Arrhythmia—Prednisone—hematologic cancer	0.000184	0.0011	CcSEcCtD
Milrinone—Angina pectoris—Doxorubicin—hematologic cancer	0.000181	0.00108	CcSEcCtD
Milrinone—Rash—Thiotepa—hematologic cancer	0.000179	0.00107	CcSEcCtD
Milrinone—Dermatitis—Thiotepa—hematologic cancer	0.000179	0.00107	CcSEcCtD
Milrinone—Headache—Thiotepa—hematologic cancer	0.000178	0.00106	CcSEcCtD
Milrinone—Rash—Thalidomide—hematologic cancer	0.000173	0.00103	CcSEcCtD
Milrinone—Dermatitis—Thalidomide—hematologic cancer	0.000173	0.00103	CcSEcCtD
Milrinone—Headache—Thalidomide—hematologic cancer	0.000172	0.00103	CcSEcCtD
Milrinone—Anaphylactic shock—Betamethasone—hematologic cancer	0.000168	0.001	CcSEcCtD
Milrinone—Anaphylactic shock—Dexamethasone—hematologic cancer	0.000168	0.001	CcSEcCtD
Milrinone—Rash—Carmustine—hematologic cancer	0.000166	0.000994	CcSEcCtD
Milrinone—Dermatitis—Carmustine—hematologic cancer	0.000166	0.000993	CcSEcCtD
Milrinone—Headache—Carmustine—hematologic cancer	0.000165	0.000988	CcSEcCtD
Milrinone—Rash—Alitretinoin—hematologic cancer	0.000165	0.000985	CcSEcCtD
Milrinone—Dermatitis—Alitretinoin—hematologic cancer	0.000165	0.000984	CcSEcCtD
Milrinone—Thrombocytopenia—Dexamethasone—hematologic cancer	0.000164	0.000982	CcSEcCtD
Milrinone—Thrombocytopenia—Betamethasone—hematologic cancer	0.000164	0.000982	CcSEcCtD
Milrinone—Headache—Alitretinoin—hematologic cancer	0.000164	0.000978	CcSEcCtD
Milrinone—Rash—Ifosfamide—hematologic cancer	0.000163	0.000973	CcSEcCtD
Milrinone—Dermatitis—Ifosfamide—hematologic cancer	0.000163	0.000972	CcSEcCtD
Milrinone—Rash—Vincristine—hematologic cancer	0.000159	0.000949	CcSEcCtD
Milrinone—Dermatitis—Vincristine—hematologic cancer	0.000159	0.000948	CcSEcCtD
Milrinone—Headache—Vincristine—hematologic cancer	0.000158	0.000943	CcSEcCtD
Milrinone—Hypotension—Dexamethasone—hematologic cancer	0.000157	0.000938	CcSEcCtD
Milrinone—Hypotension—Betamethasone—hematologic cancer	0.000157	0.000938	CcSEcCtD
Milrinone—Rash—Irinotecan—hematologic cancer	0.000155	0.000924	CcSEcCtD
Milrinone—Rash—Mitoxantrone—hematologic cancer	0.000155	0.000924	CcSEcCtD
Milrinone—Dermatitis—Mitoxantrone—hematologic cancer	0.000154	0.000923	CcSEcCtD
Milrinone—Dermatitis—Irinotecan—hematologic cancer	0.000154	0.000923	CcSEcCtD
Milrinone—Headache—Mitoxantrone—hematologic cancer	0.000154	0.000918	CcSEcCtD
Milrinone—Headache—Irinotecan—hematologic cancer	0.000154	0.000918	CcSEcCtD
Milrinone—Rash—Gemcitabine—hematologic cancer	0.000151	0.0009	CcSEcCtD
Milrinone—Dermatitis—Gemcitabine—hematologic cancer	0.00015	0.000899	CcSEcCtD
Milrinone—PDE3A—lymph node—hematologic cancer	0.00015	0.125	CbGeAlD
Milrinone—Headache—Gemcitabine—hematologic cancer	0.00015	0.000894	CcSEcCtD
Milrinone—Anaphylactic shock—Prednisone—hematologic cancer	0.000146	0.000874	CcSEcCtD
Milrinone—Arrhythmia—Epirubicin—hematologic cancer	0.000144	0.000859	CcSEcCtD
Milrinone—Rash—Cisplatin—hematologic cancer	0.00014	0.000839	CcSEcCtD
Milrinone—Dermatitis—Cisplatin—hematologic cancer	0.00014	0.000838	CcSEcCtD
Milrinone—Arrhythmia—Doxorubicin—hematologic cancer	0.000133	0.000795	CcSEcCtD
Milrinone—Rash—Etoposide—hematologic cancer	0.000129	0.000769	CcSEcCtD
Milrinone—Dermatitis—Etoposide—hematologic cancer	0.000128	0.000768	CcSEcCtD
Milrinone—Headache—Etoposide—hematologic cancer	0.000128	0.000764	CcSEcCtD
Milrinone—Chest pain—Methotrexate—hematologic cancer	0.000127	0.000762	CcSEcCtD
Milrinone—Rash—Prednisolone—hematologic cancer	0.000127	0.000758	CcSEcCtD
Milrinone—Dermatitis—Prednisolone—hematologic cancer	0.000127	0.000757	CcSEcCtD
Milrinone—Headache—Prednisolone—hematologic cancer	0.000126	0.000753	CcSEcCtD
Milrinone—Anaphylactic shock—Methotrexate—hematologic cancer	0.000122	0.00073	CcSEcCtD
Milrinone—Thrombocytopenia—Methotrexate—hematologic cancer	0.00012	0.000715	CcSEcCtD
Milrinone—Chest pain—Epirubicin—hematologic cancer	0.000119	0.000713	CcSEcCtD
Milrinone—Rash—Triamcinolone—hematologic cancer	0.000117	0.000697	CcSEcCtD
Milrinone—Dermatitis—Triamcinolone—hematologic cancer	0.000117	0.000697	CcSEcCtD
Milrinone—Headache—Triamcinolone—hematologic cancer	0.000116	0.000693	CcSEcCtD
Milrinone—Anaphylactic shock—Epirubicin—hematologic cancer	0.000114	0.000683	CcSEcCtD
Milrinone—Hypotension—Methotrexate—hematologic cancer	0.000114	0.000682	CcSEcCtD
Milrinone—Thrombocytopenia—Epirubicin—hematologic cancer	0.000112	0.000669	CcSEcCtD
Milrinone—Chest pain—Doxorubicin—hematologic cancer	0.00011	0.00066	CcSEcCtD
Milrinone—Hypotension—Epirubicin—hematologic cancer	0.000107	0.000639	CcSEcCtD
Milrinone—Rash—Betamethasone—hematologic cancer	0.000106	0.000633	CcSEcCtD
Milrinone—Rash—Dexamethasone—hematologic cancer	0.000106	0.000633	CcSEcCtD
Milrinone—Anaphylactic shock—Doxorubicin—hematologic cancer	0.000106	0.000632	CcSEcCtD
Milrinone—Dermatitis—Dexamethasone—hematologic cancer	0.000106	0.000632	CcSEcCtD
Milrinone—Dermatitis—Betamethasone—hematologic cancer	0.000106	0.000632	CcSEcCtD
Milrinone—Headache—Dexamethasone—hematologic cancer	0.000105	0.000629	CcSEcCtD
Milrinone—Headache—Betamethasone—hematologic cancer	0.000105	0.000629	CcSEcCtD
Milrinone—Thrombocytopenia—Doxorubicin—hematologic cancer	0.000104	0.000619	CcSEcCtD
Milrinone—Hypotension—Doxorubicin—hematologic cancer	9.88e-05	0.000591	CcSEcCtD
Milrinone—Rash—Prednisone—hematologic cancer	9.22e-05	0.000551	CcSEcCtD
Milrinone—Dermatitis—Prednisone—hematologic cancer	9.21e-05	0.00055	CcSEcCtD
Milrinone—Headache—Prednisone—hematologic cancer	9.16e-05	0.000547	CcSEcCtD
Milrinone—Rash—Methotrexate—hematologic cancer	7.7e-05	0.00046	CcSEcCtD
Milrinone—Dermatitis—Methotrexate—hematologic cancer	7.69e-05	0.00046	CcSEcCtD
Milrinone—Headache—Methotrexate—hematologic cancer	7.65e-05	0.000457	CcSEcCtD
Milrinone—Rash—Epirubicin—hematologic cancer	7.21e-05	0.000431	CcSEcCtD
Milrinone—Dermatitis—Epirubicin—hematologic cancer	7.2e-05	0.00043	CcSEcCtD
Milrinone—Headache—Epirubicin—hematologic cancer	7.16e-05	0.000428	CcSEcCtD
Milrinone—Rash—Doxorubicin—hematologic cancer	6.67e-05	0.000399	CcSEcCtD
Milrinone—Dermatitis—Doxorubicin—hematologic cancer	6.66e-05	0.000398	CcSEcCtD
Milrinone—Headache—Doxorubicin—hematologic cancer	6.63e-05	0.000396	CcSEcCtD
Milrinone—PDE3A—Signaling by GPCR—ARHGEF1—hematologic cancer	4.98e-05	0.00579	CbGpPWpGaD
Milrinone—PDE3A—GPCR downstream signaling—CXCR5—hematologic cancer	4.83e-05	0.00561	CbGpPWpGaD
Milrinone—PDE3A—Hemostasis—SPARC—hematologic cancer	4.76e-05	0.00553	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—PPEF1—hematologic cancer	4.69e-05	0.00545	CbGpPWpGaD
Milrinone—PDE3A—GPCR downstream signaling—GNA13—hematologic cancer	4.67e-05	0.00542	CbGpPWpGaD
Milrinone—PDE3A—Hemostasis—LCK—hematologic cancer	4.61e-05	0.00536	CbGpPWpGaD
Milrinone—PDE3A—GPCR downstream signaling—TIAM1—hematologic cancer	4.59e-05	0.00534	CbGpPWpGaD
Milrinone—PDE3A—Hemostasis—H3F3A—hematologic cancer	4.52e-05	0.00525	CbGpPWpGaD
Milrinone—PDE3A—Hemostasis—GATA3—hematologic cancer	4.47e-05	0.0052	CbGpPWpGaD
Milrinone—PDE3A—Signaling by GPCR—CCL17—hematologic cancer	4.47e-05	0.00519	CbGpPWpGaD
Milrinone—PDE3A—Hemostasis—HSPA5—hematologic cancer	4.45e-05	0.00517	CbGpPWpGaD
Milrinone—PDE3A—GPCR downstream signaling—JAK3—hematologic cancer	4.45e-05	0.00517	CbGpPWpGaD
Milrinone—PDE3A—Hemostasis—PRKCZ—hematologic cancer	4.39e-05	0.0051	CbGpPWpGaD
Milrinone—PDE3A—Signaling by GPCR—CXCR5—hematologic cancer	4.39e-05	0.0051	CbGpPWpGaD
Milrinone—PDE3A—GPCR downstream signaling—CCR7—hematologic cancer	4.27e-05	0.00496	CbGpPWpGaD
Milrinone—PDE3A—GPCR downstream signaling—CXCL13—hematologic cancer	4.27e-05	0.00496	CbGpPWpGaD
Milrinone—PDE3A—Signaling by GPCR—GNA13—hematologic cancer	4.24e-05	0.00492	CbGpPWpGaD
Milrinone—PDE3A—Signaling by GPCR—TIAM1—hematologic cancer	4.17e-05	0.00484	CbGpPWpGaD
Milrinone—PDE3A—GPCR downstream signaling—IL3RA—hematologic cancer	4.16e-05	0.00483	CbGpPWpGaD
Milrinone—PDE3A—Hemostasis—HDAC2—hematologic cancer	4.09e-05	0.00475	CbGpPWpGaD
Milrinone—PDE3A—Hemostasis—CD44—hematologic cancer	4.04e-05	0.0047	CbGpPWpGaD
Milrinone—PDE3A—Hemostasis—ITGA4—hematologic cancer	4.04e-05	0.0047	CbGpPWpGaD
Milrinone—PDE3A—Signaling by GPCR—JAK3—hematologic cancer	4.04e-05	0.0047	CbGpPWpGaD
Milrinone—PDE3A—GPCR downstream signaling—RGS2—hematologic cancer	4.01e-05	0.00466	CbGpPWpGaD
Milrinone—PDE3A—GPCR downstream signaling—TRH—hematologic cancer	3.97e-05	0.00461	CbGpPWpGaD
Milrinone—PDE3A—GPCR downstream signaling—TRIO—hematologic cancer	3.97e-05	0.00461	CbGpPWpGaD
Milrinone—PDE3A—Hemostasis—IL3—hematologic cancer	3.94e-05	0.00458	CbGpPWpGaD
Milrinone—PDE3A—Hemostasis—IFNA1—hematologic cancer	3.92e-05	0.00455	CbGpPWpGaD
Milrinone—PDE3A—Hemostasis—PTPN1—hematologic cancer	3.88e-05	0.00451	CbGpPWpGaD
Milrinone—PDE3A—Signaling by GPCR—CCR7—hematologic cancer	3.87e-05	0.0045	CbGpPWpGaD
Milrinone—PDE3A—Signaling by GPCR—CXCL13—hematologic cancer	3.87e-05	0.0045	CbGpPWpGaD
Milrinone—PDE3A—GPCR downstream signaling—LPAR1—hematologic cancer	3.84e-05	0.00447	CbGpPWpGaD
Milrinone—PDE3A—Hemostasis—RASGRP1—hematologic cancer	3.81e-05	0.00443	CbGpPWpGaD
Milrinone—PDE3A—Hemostasis—SYK—hematologic cancer	3.8e-05	0.00442	CbGpPWpGaD
Milrinone—PDE3A—Signaling by GPCR—IL3RA—hematologic cancer	3.78e-05	0.00439	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—HDAC11—hematologic cancer	3.7e-05	0.00431	CbGpPWpGaD
Milrinone—PDE3A—Hemostasis—IFNA2—hematologic cancer	3.65e-05	0.00424	CbGpPWpGaD
Milrinone—PDE3A—Signaling by GPCR—RGS2—hematologic cancer	3.64e-05	0.00423	CbGpPWpGaD
Milrinone—PDE3A—Signaling by GPCR—TRH—hematologic cancer	3.6e-05	0.00419	CbGpPWpGaD
Milrinone—PDE3A—Signaling by GPCR—TRIO—hematologic cancer	3.6e-05	0.00419	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—BCR—hematologic cancer	3.55e-05	0.00413	CbGpPWpGaD
Milrinone—PDE3A—GPCR downstream signaling—PDE4B—hematologic cancer	3.54e-05	0.00411	CbGpPWpGaD
Milrinone—PDE3A—GPCR downstream signaling—CNR2—hematologic cancer	3.54e-05	0.00411	CbGpPWpGaD
Milrinone—PDE3A—Signaling by GPCR—LPAR1—hematologic cancer	3.49e-05	0.00406	CbGpPWpGaD
Milrinone—PDE3A—GPCR downstream signaling—RAC2—hematologic cancer	3.48e-05	0.00404	CbGpPWpGaD
Milrinone—PDE3A—Hemostasis—GRB2—hematologic cancer	3.43e-05	0.00399	CbGpPWpGaD
Milrinone—PDE3A—Hemostasis—PDGFA—hematologic cancer	3.42e-05	0.00398	CbGpPWpGaD
Milrinone—PDE3A—GPCR downstream signaling—ADCY7—hematologic cancer	3.32e-05	0.00386	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—HDAC10—hematologic cancer	3.3e-05	0.00384	CbGpPWpGaD
Milrinone—PDE3A—Hemostasis—ABL1—hematologic cancer	3.3e-05	0.00383	CbGpPWpGaD
Milrinone—PDE3A—Signaling by GPCR—PDE4B—hematologic cancer	3.21e-05	0.00373	CbGpPWpGaD
Milrinone—PDE3A—Signaling by GPCR—CNR2—hematologic cancer	3.21e-05	0.00373	CbGpPWpGaD
Milrinone—PDE3A—Signaling by GPCR—RAC2—hematologic cancer	3.16e-05	0.00367	CbGpPWpGaD
Milrinone—PDE3A—Hemostasis—HGF—hematologic cancer	3.1e-05	0.0036	CbGpPWpGaD
Milrinone—PDE3A—Hemostasis—CSF2—hematologic cancer	3.07e-05	0.00356	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—ARHGEF12—hematologic cancer	3.02e-05	0.00351	CbGpPWpGaD
Milrinone—PDE3A—Signaling by GPCR—ADCY7—hematologic cancer	3.02e-05	0.00351	CbGpPWpGaD
Milrinone—PDE3A—GPCR downstream signaling—PTHLH—hematologic cancer	3.01e-05	0.00349	CbGpPWpGaD
Milrinone—PDE3A—Hemostasis—JAK1—hematologic cancer	2.96e-05	0.00344	CbGpPWpGaD
Milrinone—PDE3A—Hemostasis—PRKCG—hematologic cancer	2.96e-05	0.00344	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—ARHGEF1—hematologic cancer	2.94e-05	0.00342	CbGpPWpGaD
Milrinone—PDE3A—GPCR downstream signaling—PTGER4—hematologic cancer	2.93e-05	0.0034	CbGpPWpGaD
Milrinone—PDE3A—Hemostasis—IL2RA—hematologic cancer	2.76e-05	0.00321	CbGpPWpGaD
Milrinone—PDE3A—Signaling by GPCR—CCL3—hematologic cancer	2.76e-05	0.00321	CbGpPWpGaD
Milrinone—PDE3A—Signaling by GPCR—PTHLH—hematologic cancer	2.73e-05	0.00317	CbGpPWpGaD
Milrinone—PDE3A—Hemostasis—PDGFB—hematologic cancer	2.67e-05	0.0031	CbGpPWpGaD
Milrinone—PDE3A—Signaling by GPCR—PTGER4—hematologic cancer	2.66e-05	0.00309	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—CCL17—hematologic cancer	2.64e-05	0.00307	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—AGRN—hematologic cancer	2.64e-05	0.00307	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—CXCR5—hematologic cancer	2.59e-05	0.00301	CbGpPWpGaD
Milrinone—PDE3A—Hemostasis—CDK2—hematologic cancer	2.59e-05	0.00301	CbGpPWpGaD
Milrinone—PDE3A—GPCR downstream signaling—CXCR4—hematologic cancer	2.59e-05	0.003	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—LEF1—hematologic cancer	2.55e-05	0.00296	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—GNA13—hematologic cancer	2.5e-05	0.00291	CbGpPWpGaD
Milrinone—PDE3A—GPCR downstream signaling—IL3—hematologic cancer	2.49e-05	0.0029	CbGpPWpGaD
Milrinone—PDE3A—Hemostasis—MAPK14—hematologic cancer	2.48e-05	0.00289	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—TIAM1—hematologic cancer	2.46e-05	0.00286	CbGpPWpGaD
Milrinone—PDE3A—GPCR downstream signaling—RASGRP1—hematologic cancer	2.41e-05	0.0028	CbGpPWpGaD
Milrinone—PDE3A—Hemostasis—FN1—hematologic cancer	2.41e-05	0.0028	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—JAK3—hematologic cancer	2.39e-05	0.00278	CbGpPWpGaD
Milrinone—PDE3A—Signaling by GPCR—CXCR4—hematologic cancer	2.35e-05	0.00273	CbGpPWpGaD
Milrinone—PDE3A—Hemostasis—PIK3CG—hematologic cancer	2.3e-05	0.00268	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—CXCL13—hematologic cancer	2.29e-05	0.00266	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—CCR7—hematologic cancer	2.29e-05	0.00266	CbGpPWpGaD
Milrinone—PDE3A—Signaling by GPCR—IL3—hematologic cancer	2.26e-05	0.00263	CbGpPWpGaD
Milrinone—PDE3A—Hemostasis—PTPN11—hematologic cancer	2.26e-05	0.00263	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—NCOR2—hematologic cancer	2.26e-05	0.00263	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—IL3RA—hematologic cancer	2.23e-05	0.00259	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—CRKL—hematologic cancer	2.23e-05	0.00259	CbGpPWpGaD
Milrinone—PDE3A—Signaling by GPCR—RASGRP1—hematologic cancer	2.19e-05	0.00254	CbGpPWpGaD
Milrinone—PDE3A—GPCR downstream signaling—GRB2—hematologic cancer	2.17e-05	0.00252	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—RGS2—hematologic cancer	2.15e-05	0.0025	CbGpPWpGaD
Milrinone—PDE3A—Hemostasis—CREBBP—hematologic cancer	2.13e-05	0.00248	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—CMA1—hematologic cancer	2.13e-05	0.00247	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—TRH—hematologic cancer	2.13e-05	0.00247	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—TRIO—hematologic cancer	2.13e-05	0.00247	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—SPHK1—hematologic cancer	2.08e-05	0.00242	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—AGO2—hematologic cancer	2.08e-05	0.00242	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—LPAR1—hematologic cancer	2.06e-05	0.0024	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—HDAC9—hematologic cancer	2.06e-05	0.0024	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—H3F3B—hematologic cancer	2.04e-05	0.00237	CbGpPWpGaD
Milrinone—PDE3A—Hemostasis—PIK3CD—hematologic cancer	2.02e-05	0.00235	CbGpPWpGaD
Milrinone—PDE3A—Hemostasis—ALB—hematologic cancer	2e-05	0.00232	CbGpPWpGaD
Milrinone—PDE3A—Signaling by GPCR—GRB2—hematologic cancer	1.97e-05	0.00229	CbGpPWpGaD
Milrinone—PDE3A—GPCR downstream signaling—CSF2—hematologic cancer	1.94e-05	0.00225	CbGpPWpGaD
Milrinone—PDE3A—Hemostasis—PIK3R1—hematologic cancer	1.91e-05	0.00222	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—PDE4B—hematologic cancer	1.9e-05	0.0022	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—CNR2—hematologic cancer	1.9e-05	0.0022	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—FGF19—hematologic cancer	1.88e-05	0.00219	CbGpPWpGaD
Milrinone—PDE3A—GPCR downstream signaling—PRKCG—hematologic cancer	1.87e-05	0.00217	CbGpPWpGaD
Milrinone—PDE3A—GPCR downstream signaling—JAK1—hematologic cancer	1.87e-05	0.00217	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—RAC2—hematologic cancer	1.87e-05	0.00217	CbGpPWpGaD
Milrinone—PDE3A—Hemostasis—JAK2—hematologic cancer	1.86e-05	0.00216	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—DKK1—hematologic cancer	1.85e-05	0.00215	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—STAT5B—hematologic cancer	1.84e-05	0.00214	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—ADCY7—hematologic cancer	1.78e-05	0.00207	CbGpPWpGaD
Milrinone—PDE3A—Hemostasis—PIK3CB—hematologic cancer	1.76e-05	0.00205	CbGpPWpGaD
Milrinone—PDE3A—Signaling by GPCR—CSF2—hematologic cancer	1.76e-05	0.00204	CbGpPWpGaD
Milrinone—PDE3A—GPCR downstream signaling—IL2RA—hematologic cancer	1.75e-05	0.00203	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—XIAP—hematologic cancer	1.73e-05	0.00202	CbGpPWpGaD
Milrinone—PDE3A—Signaling by GPCR—JAK1—hematologic cancer	1.7e-05	0.00197	CbGpPWpGaD
Milrinone—PDE3A—Signaling by GPCR—PRKCG—hematologic cancer	1.7e-05	0.00197	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—SMARCA4—hematologic cancer	1.69e-05	0.00197	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—SH2B3—hematologic cancer	1.69e-05	0.00197	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—GZMB—hematologic cancer	1.68e-05	0.00195	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—CTNNA1—hematologic cancer	1.64e-05	0.00191	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—EIF4EBP1—hematologic cancer	1.63e-05	0.0019	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—HSPB1—hematologic cancer	1.63e-05	0.0019	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—CCL3—hematologic cancer	1.63e-05	0.0019	CbGpPWpGaD
Milrinone—PDE3A—Hemostasis—IL2—hematologic cancer	1.62e-05	0.00188	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—PTHLH—hematologic cancer	1.61e-05	0.00187	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—SDC1—hematologic cancer	1.61e-05	0.00187	CbGpPWpGaD
Milrinone—PDE3A—Signaling by GPCR—IL2RA—hematologic cancer	1.59e-05	0.00184	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—PTGER4—hematologic cancer	1.57e-05	0.00182	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—LCK—hematologic cancer	1.56e-05	0.00182	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—H3F3A—hematologic cancer	1.53e-05	0.00178	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—PRKCZ—hematologic cancer	1.49e-05	0.00173	CbGpPWpGaD
Milrinone—PDE3A—GPCR downstream signaling—PIK3CG—hematologic cancer	1.45e-05	0.00169	CbGpPWpGaD
Milrinone—PDE3A—Hemostasis—EP300—hematologic cancer	1.45e-05	0.00169	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—PARP1—hematologic cancer	1.44e-05	0.00167	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—FBXW7—hematologic cancer	1.41e-05	0.00164	CbGpPWpGaD
Milrinone—PDE3A—Hemostasis—SRC—hematologic cancer	1.41e-05	0.00164	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—HDAC2—hematologic cancer	1.39e-05	0.00161	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—CXCR4—hematologic cancer	1.39e-05	0.00161	CbGpPWpGaD
Milrinone—PDE3A—Hemostasis—VEGFA—hematologic cancer	1.38e-05	0.0016	CbGpPWpGaD
Milrinone—PDE3A—Hemostasis—NRAS—hematologic cancer	1.36e-05	0.00158	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—CBL—hematologic cancer	1.35e-05	0.00157	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—IL3—hematologic cancer	1.34e-05	0.00155	CbGpPWpGaD
Milrinone—PDE3A—Signaling by GPCR—PIK3CG—hematologic cancer	1.32e-05	0.00154	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—PTPN1—hematologic cancer	1.31e-05	0.00153	CbGpPWpGaD
Milrinone—PDE3A—Hemostasis—MAPK3—hematologic cancer	1.3e-05	0.00151	CbGpPWpGaD
Milrinone—PDE3A—Signaling by GPCR—PTPN11—hematologic cancer	1.3e-05	0.00151	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—RASGRP1—hematologic cancer	1.29e-05	0.0015	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—HSP90AA1—hematologic cancer	1.29e-05	0.0015	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—SYK—hematologic cancer	1.29e-05	0.0015	CbGpPWpGaD
Milrinone—PDE3A—GPCR downstream signaling—PIK3CD—hematologic cancer	1.28e-05	0.00149	CbGpPWpGaD
Milrinone—PDE3A—Hemostasis—TGFB1—hematologic cancer	1.26e-05	0.00147	CbGpPWpGaD
Milrinone—PDE3A—Signaling by GPCR—CREB1—hematologic cancer	1.26e-05	0.00146	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—STAT1—hematologic cancer	1.24e-05	0.00145	CbGpPWpGaD
Milrinone—PDE3A—Signaling by GPCR—CCL2—hematologic cancer	1.23e-05	0.00143	CbGpPWpGaD
Milrinone—PDE3A—Signaling by GPCR—IL6R—hematologic cancer	1.23e-05	0.00143	CbGpPWpGaD
Milrinone—PDE3A—GPCR downstream signaling—PIK3R1—hematologic cancer	1.21e-05	0.0014	CbGpPWpGaD
Milrinone—PDE3A—GPCR downstream signaling—JAK2—hematologic cancer	1.17e-05	0.00136	CbGpPWpGaD
Milrinone—PDE3A—Hemostasis—KRAS—hematologic cancer	1.17e-05	0.00136	CbGpPWpGaD
Milrinone—PDE3A—Signaling by GPCR—MAP2K1—hematologic cancer	1.17e-05	0.00136	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—GRB2—hematologic cancer	1.16e-05	0.00135	CbGpPWpGaD
Milrinone—PDE3A—Signaling by GPCR—PIK3CD—hematologic cancer	1.16e-05	0.00135	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—PDGFA—hematologic cancer	1.16e-05	0.00135	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—KITLG—hematologic cancer	1.14e-05	0.00133	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—STAT5A—hematologic cancer	1.12e-05	0.0013	CbGpPWpGaD
Milrinone—PDE3A—GPCR downstream signaling—PIK3CB—hematologic cancer	1.11e-05	0.0013	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—CDKN2B—hematologic cancer	1.11e-05	0.00129	CbGpPWpGaD
Milrinone—PDE3A—Signaling by GPCR—PIK3R1—hematologic cancer	1.1e-05	0.00127	CbGpPWpGaD
Milrinone—PDE3A—Hemostasis—PIK3CA—hematologic cancer	1.08e-05	0.00125	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—CD86—hematologic cancer	1.07e-05	0.00125	CbGpPWpGaD
Milrinone—PDE3A—Signaling by GPCR—JAK2—hematologic cancer	1.07e-05	0.00124	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—HES1—hematologic cancer	1.06e-05	0.00123	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—NCOR1—hematologic cancer	1.05e-05	0.00122	CbGpPWpGaD
Milrinone—PDE3A—Hemostasis—TP53—hematologic cancer	1.04e-05	0.00121	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—FGF1—hematologic cancer	1.04e-05	0.00121	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—CSF2—hematologic cancer	1.04e-05	0.00121	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—FOXO1—hematologic cancer	1.02e-05	0.00119	CbGpPWpGaD
Milrinone—PDE3A—GPCR downstream signaling—IL2—hematologic cancer	1.02e-05	0.00119	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—PDGFRB—hematologic cancer	1.02e-05	0.00119	CbGpPWpGaD
Milrinone—PDE3A—Signaling by GPCR—PIK3CB—hematologic cancer	1.01e-05	0.00118	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—PDGFRA—hematologic cancer	1.01e-05	0.00117	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—JAK1—hematologic cancer	1e-05	0.00117	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—PRKCG—hematologic cancer	1e-05	0.00117	CbGpPWpGaD
Milrinone—PDE3A—Hemostasis—HRAS—hematologic cancer	9.95e-06	0.00116	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—IL2RA—hematologic cancer	9.37e-06	0.00109	CbGpPWpGaD
Milrinone—PDE3A—Signaling by GPCR—IL2—hematologic cancer	9.3e-06	0.00108	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—TERT—hematologic cancer	9.26e-06	0.00108	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—PDGFB—hematologic cancer	9.04e-06	0.00105	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—TSC2—hematologic cancer	8.84e-06	0.00103	CbGpPWpGaD
Milrinone—PDE3A—Hemostasis—AKT1—hematologic cancer	8.78e-06	0.00102	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—FGFR3—hematologic cancer	8.5e-06	0.000988	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—MAPK14—hematologic cancer	8.42e-06	0.000978	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—ESR1—hematologic cancer	8.26e-06	0.00096	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—FN1—hematologic cancer	8.15e-06	0.000948	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—BAD—hematologic cancer	8.06e-06	0.000937	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—NFKBIA—hematologic cancer	8.06e-06	0.000937	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—NOTCH1—hematologic cancer	7.98e-06	0.000928	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—CD80—hematologic cancer	7.82e-06	0.000909	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—PIK3CG—hematologic cancer	7.8e-06	0.000907	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—KIT—hematologic cancer	7.8e-06	0.000907	CbGpPWpGaD
Milrinone—PDE3A—Signaling by GPCR—NRAS—hematologic cancer	7.8e-06	0.000907	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—PTPN11—hematologic cancer	7.67e-06	0.000891	CbGpPWpGaD
Milrinone—PDE3A—Signaling by GPCR—MAPK3—hematologic cancer	7.47e-06	0.000869	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—CREB1—hematologic cancer	7.43e-06	0.000863	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—BRAF—hematologic cancer	7.34e-06	0.000853	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—CCL2—hematologic cancer	7.27e-06	0.000845	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—IL6R—hematologic cancer	7.25e-06	0.000842	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—CREBBP—hematologic cancer	7.24e-06	0.000841	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—MAP2K1—hematologic cancer	6.91e-06	0.000803	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—PIK3CD—hematologic cancer	6.86e-06	0.000797	CbGpPWpGaD
Milrinone—PDE3A—GPCR downstream signaling—PIK3CA—hematologic cancer	6.8e-06	0.00079	CbGpPWpGaD
Milrinone—PDE3A—Signaling by GPCR—KRAS—hematologic cancer	6.72e-06	0.000781	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—FGF2—hematologic cancer	6.57e-06	0.000764	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—PIK3R1—hematologic cancer	6.48e-06	0.000753	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—JAK2—hematologic cancer	6.3e-06	0.000732	CbGpPWpGaD
Milrinone—PDE3A—Signaling by GPCR—PIK3CA—hematologic cancer	6.17e-06	0.000717	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—MDM2—hematologic cancer	6.15e-06	0.000714	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—MTOR—hematologic cancer	5.98e-06	0.000695	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—PIK3CB—hematologic cancer	5.98e-06	0.000695	CbGpPWpGaD
Milrinone—PDE3A—Signaling by GPCR—HRAS—hematologic cancer	5.71e-06	0.000664	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—CDKN1B—hematologic cancer	5.61e-06	0.000652	CbGpPWpGaD
Milrinone—PDE3A—GPCR downstream signaling—AKT1—hematologic cancer	5.55e-06	0.000645	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—CASP3—hematologic cancer	5.5e-06	0.000639	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—IL2—hematologic cancer	5.49e-06	0.000638	CbGpPWpGaD
Milrinone—PDE3A—Signaling by GPCR—IL6—hematologic cancer	5.46e-06	0.000635	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—CCND1—hematologic cancer	5.35e-06	0.000622	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—JUN—hematologic cancer	5.34e-06	0.000621	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—CDKN1A—hematologic cancer	5.18e-06	0.000602	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—PTEN—hematologic cancer	5.17e-06	0.000601	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—MAPK8—hematologic cancer	5.05e-06	0.000588	CbGpPWpGaD
Milrinone—PDE3A—Signaling by GPCR—AKT1—hematologic cancer	5.04e-06	0.000586	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—EP300—hematologic cancer	4.93e-06	0.000573	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—SRC—hematologic cancer	4.79e-06	0.000557	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—VEGFA—hematologic cancer	4.67e-06	0.000543	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—STAT3—hematologic cancer	4.62e-06	0.000537	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—NRAS—hematologic cancer	4.61e-06	0.000536	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—MAPK3—hematologic cancer	4.41e-06	0.000513	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—MYC—hematologic cancer	4.29e-06	0.000499	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—TGFB1—hematologic cancer	4.28e-06	0.000498	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—KRAS—hematologic cancer	3.97e-06	0.000461	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—PIK3CA—hematologic cancer	3.65e-06	0.000424	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—TP53—hematologic cancer	3.53e-06	0.00041	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—HRAS—hematologic cancer	3.37e-06	0.000392	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—IL6—hematologic cancer	3.23e-06	0.000375	CbGpPWpGaD
Milrinone—PDE3A—Signaling Pathways—AKT1—hematologic cancer	2.98e-06	0.000346	CbGpPWpGaD
